Moderna's mRNA Flu Vaccine, mFLUSIVA, Gains FDA Approval for Adults 50+
Moderna has received Food and Drug Administration approval for its mRNA-based flu vaccine, mFLUSIVA, for individuals aged 50 and older, despite a contentious review process.
Archive
Moderna has received Food and Drug Administration approval for its mRNA-based flu vaccine, mFLUSIVA, for individuals aged 50 and older, despite a contentious review process.
A California labor union has initiated legal action against the state regarding new regulations that permit the operation of self-driving trucks on public roads.
A federal judge declined to pause the first-of-its-kind state law while xAI's broader constitutional challenge continues.
The temporary generators will remain while a permanent 1.2-gigawatt gas plant is built for the Colossus data centers.
Apple still set a quarterly services record, but regulatory pressure and softer gaming activity limited growth in key areas.
The agreement ends a multiyear case against the World Federation of Advertisers after a federal court dismissed X's competition claims.
The robotics startup introduced its first commercial hand and closed a seed round after settling a trade-secret dispute with Tesla.
The San Francisco startup reached a $2.2 billion valuation by selling web search and content retrieval directly to software developers.
The vertical software company is connecting agency data with AI workflows for policy checks, proposals and other document-heavy tasks.
The full-stack insurer is using AI across underwriting, policy administration and claims as it expands into additional commercial markets.
The music model can create structured tracks of up to three minutes and is available across developer, enterprise and creative products.